Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
Anna Wilkaniec, Anna M. Lenkiewicz, Grzegorz A. Czapski, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 1, pp. 125-140
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

The Role of α-Synuclein Oligomers in Parkinson’s Disease
Xiaoyu Du, Xi-xiu Xie, Rui‐tian Liu
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8645-8645
Open Access | Times Cited: 165
The interplay between mitochondrial dynamics and autophagy: From a key homeostatic mechanism to a driver of pathology
Alice Lacombe, Luca Scorrano
Seminars in Cell and Developmental Biology (2024) Vol. 161-162, pp. 1-19
Open Access | Times Cited: 19
Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration
Tomohiro Nakamura, Chang-ki Oh, Xu Zhang, et al.
Free Radical Biology and Medicine (2021) Vol. 172, pp. 562-577
Open Access | Times Cited: 60
The relationship of alpha-synuclein to mitochondrial dynamics and quality control
Naomi J. Thorne, David A. Tumbarello
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 40
Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions
Mani Iyer Prasanth, Bhagavathi Sundaram Sivamaruthi, Clerance Su Yee Cheong, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 606-606
Open Access | Times Cited: 12
NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin
Yiqun Yan, Yi Fang, Ran Zheng, et al.
Neuroscience (2020) Vol. 446, pp. 323-334
Open Access | Times Cited: 57
Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease
Daniel Aghaie Madsen, Sissel Ida Schmidt, Morten Blaabjerg, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 283-283
Open Access | Times Cited: 53
S-Glutathionylation and S-Nitrosylation in Mitochondria: Focus on Homeostasis and Neurodegenerative Diseases
Sofia Vrettou, Brunhilde Wirth
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15849-15849
Open Access | Times Cited: 28
Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative Diseases
Tomohiro Nakamura, Stuart A. Lipton
Antioxidants and Redox Signaling (2019) Vol. 32, Iss. 12, pp. 817-833
Open Access | Times Cited: 49
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
K. A. Jellinger
Journal of Neural Transmission (2019) Vol. 126, Iss. 8, pp. 933-995
Closed Access | Times Cited: 43
Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology
Anna Wilkaniec, Anna M. Lenkiewicz, Lidia Babiec, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 38
The Role of NEDD4 E3 Ubiquitin–Protein Ligases in Parkinson’s Disease
James A. Conway, Grant Kinsman, Edgar R. Kramer
Genes (2022) Vol. 13, Iss. 3, pp. 513-513
Open Access | Times Cited: 24
Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease
Kajal Sharma, Shivani Chib, Anil Gupta, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson’s Disease Models
Mingxia Bi, Xixun Du, Qian Jiao, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 11, pp. 1682-1691
Closed Access | Times Cited: 34
P2X7 Receptor is Involved in Mitochondrial Dysfunction Induced by Extracellular Alpha Synuclein in Neuroblastoma SH-SY5Y Cells
Anna Wilkaniec, Magdalena Cieślik, Emilia Murawska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3959-3959
Open Access | Times Cited: 33
Melatonin, Its Metabolites and Their Interference with Reactive Nitrogen Compounds
Rüdiger Hardeland
Molecules (2021) Vol. 26, Iss. 13, pp. 4105-4105
Open Access | Times Cited: 29
Extracellular alpha-synuclein: Sensors, receptors, and responses
Renato Domingues, Ricardo Sant’Anna, Anna Carolina Carvalho da Fonseca, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105696-105696
Open Access | Times Cited: 21
Analysis of α-syn and parkin interaction in mediating neuronal death in Drosophila model of Parkinson's disease
Sonia Narwal, Amit Singh, Meghana Tare
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 4
Factors responsible for alpha-Synuclein aggregation
Khuraijam Surjalal Singh, Rahul Verma, N. Okendro Singh, et al.
Progress in molecular biology and translational science (2025)
Closed Access
Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson’s Disease Models
Hefeng Zhou, Min Shao, Baojian Guo, et al.
Neurotherapeutics (2019) Vol. 16, Iss. 4, pp. 1225-1236
Open Access | Times Cited: 34
The Relationship Between Protein S-Nitrosylation and Human Diseases: A Review
Yadi Zhang, Yuzhen Deng, Xiaoxi Yang, et al.
Neurochemical Research (2020) Vol. 45, Iss. 12, pp. 2815-2827
Closed Access | Times Cited: 31
X1INH, an improved next-generation affinity-optimized hydrazonic ligand, attenuates abnormal copper(i)/copper(ii)-α-Syn interactions and affects protein aggregation in a cellular model of synucleinopathy
Daphne S. Cukierman, Diana F. Lázaro, Pamela Sacco, et al.
Dalton Transactions (2020) Vol. 49, Iss. 45, pp. 16252-16267
Closed Access | Times Cited: 28
The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson’s disease
Henryk Jęśko, Anna M. Lenkiewicz, Anna Wilkaniec, et al.
Acta Neurobiologiae Experimentalis (2019) Vol. 79, Iss. 3, pp. 277-290
Open Access | Times Cited: 28
Dysfunctional proteins in neuropsychiatric disorders: From neurodegeneration to autism spectrum disorders
Henryk Jęśko, Magdalena Cieślik, Grażyna Gromadzka, et al.
Neurochemistry International (2020) Vol. 141, pp. 104853-104853
Closed Access | Times Cited: 24
Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson's disease models
Aurélie de Rus Jacquet, A. Ambaw, Mitali A. Tambe, et al.
Food & Function (2021) Vol. 12, Iss. 23, pp. 11987-12007
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top